Litcius/Paper detail

Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry

Roni Shouval, Joshua Fein, Myriam Labopin, Christina Cho, Ali Bazarbachi, Frédéric Baron, Gesine Bug, Fabio Ciceri, Selim Corbacioglu, Jacques‐Emmanuel Galimard, Sebastian Giebel, Maria Gilleece, Sergio Giralt, Ann A. Jakubowski, Silvia Montoto, Richard J. O’Reilly, Esperanza B. Papadopoulos, Zinaida Perić, Annalisa Ruggeri, Jaime Sanz, Craig S. Sauter, Bipin N. Savani, Christoph Schmid, Alexandros Spyridonidis, Roni Tamari, Jurjen Versluis, Ibrahim Yakoub‐Agha, Miguel‐Angel Perales, Mohamad Mohty, Arnon Nagler

2021The Lancet Haematology34 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCohortTransplantationHazard ratioInternal medicineProportional hazards modelRetrospective cohort studyHematopoietic stem cell transplantationMyelodysplastic syndromesCohort studyOncologyBone marrowConfidence intervalMultiple Myeloma Research and TreatmentsHematopoietic Stem Cell TransplantationAcute Myeloid Leukemia Research
Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry | Litcius